Shivalik Rasayan Ltd issues LOA to Medicamen Biotech Ltd to use its DMF grade Bortezomib API

Shivalik Rasayan Limited has issued LOA (Letter of Authorisation) to Medicamen Biotech Limited, to use its DMF grade Bortezomib API for formulation of Bortezomib injection 3.5mg/ vial.

Medicamen Biotech Limited has filed its first ANDA with USFDA today.

Shares of Shivalik Rasayan Ltd was last trading in BSE at Rs. 754.35 as compared to the previous close of Rs. 736.25. The total number of shares traded during the day was 4160 in over 400 trades.

The stock hit an intraday high of Rs. 765.05 and intraday low of 730.00. The net turnover during the day was Rs. 3144277.00.

Source : Equity Bulls

Keywords

ShivalikRasayan INE788J01021 LOA MedicamenBiotech DMFGrade BortezomibAPI USFDA ANDA